MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

Medicines beginning with A

Asenapine

Asenapine 3.8mg/24hours transdermal patches

No stability information

Stability notes for Asenapine 3.8mg/24hours transdermal patches

There are no stability notes for this medicine.

Supplier

Asenapine 3.8mg/24hours transdermal patches (Imported)

Asenapine 5.7mg/24hours transdermal patches

No stability information

Stability notes for Asenapine 5.7mg/24hours transdermal patches

There are no stability notes for this medicine.

Supplier

Asenapine 5.7mg/24hours transdermal patches (Imported)

Asenapine 5mg sublingual tablets sugar free

Incompatible

Stability notes for Asenapine 5mg sublingual tablets sugar free

There are no stability notes for this medicine.

Provenance

).

Supplier

Asenapine 5mg sublingual tablets sugar free (Imported)

Asenapine 7.6mg/24hours transdermal patches

No stability information

Stability notes for Asenapine 7.6mg/24hours transdermal patches

There are no stability notes for this medicine.

Supplier

Asenapine 7.6mg/24hours transdermal patches (Imported)

Asenapine 10mg sublingual tablets sugar free

Incompatible

Stability notes for Asenapine 10mg sublingual tablets sugar free

There are no stability notes for this medicine.

Supplier

Asenapine 10mg sublingual tablets sugar free (Imported)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.